Genetic tests




Rodinia is a genetic test that detects changes in genes associated with male infertility. The panel includes 40 genes and detects abnormalities of the sex chromosomes (X and Y), including Y chromosome microdeletions.

Rodinia is a genetic test that detects changes in genes associated with female infertility. The panel analyzes the complete coding sequences of 55 genes and assesses sex chromosome aneuploidies, including changes in number, structural alterations, and mosaic variants.

Histopathological evaluation of cancer tissue involves assessing the quality of the biopsy material, which is then prepared for ForeSentia genetic testing.

Adventia is a state-of-the-art genetic screening test that can determine whether a person without symptoms is a carrier of a genetic disease. The genetic information provided by Adventia can help you make informed family planning decisions, reducing the risk of passing a genetic disease to your offspring. Adventia, a comprehensive panel, is a study that includes 231 genes associated with diseases with an autosomal recessive and X-chromosome-coupled inheritance model.

Adventia is a state-of-the-art genetic screening test that can determine whether a person without symptoms is a carrier of a genetic disease. The genetic information provided by Adventia can help you make informed family planning decisions, reducing the risk of passing a genetic disease to your offspring. Adventia, a comprehensive panel, is a study that includes 231 genes associated with diseases with an autosomal recessive and X-chromosome-coupled inheritance model.

Adventia is a state-of-the-art genetic screening test that can determine whether a person without symptoms is a carrier of a genetic disease.
The description refers to the test in the basic panel version for a couple.

Adventia is a state-of-the-art genetic screening test that can determine whether a person without symptoms is a carrier of a genetic disease.
The description refers to the test in the version of the basic panel for one person.

ForeSENTIA Pan-Cancer is an advanced oncogenetic test that allows molecular profiling of the tumor. This makes it possible to apply targeted therapy tailored to the individual patient's needs.

ForeSENTIA Pan-Cancer is an advanced oncogenetic test that allows molecular profiling of the tumor. This makes it possible to apply targeted therapy tailored to the individual patient's needs.